Today, Bronfman E.L. Rothschild L.P. Reached $506,000 position of Varian Medical Systems Inc. (VAR)

Today, Bronfman E.L. Rothschild L.P. Reached $506,000 position  of Varian Medical Systems Inc. (VAR)

Bronfman E.L. Rothschild L.P. raised its position in shares of Varian Medical Systems Inc. (NYSE:VAR) by 41.2% during the third quarter, Holdings Channel reports. The institutional investor owned 5,080 shares of the company’s stock after buying an additional 1,483 shares during the period. Bronfman E.L. Rothschild L.P.’s holdings in Varian Medical Systems were worth $506,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the stock. Panagora Asset Management Inc. raised its stake in shares of Varian Medical Systems by 23.1% in the first quarter. Panagora Asset Management Inc. now owns 166,606 shares of the company’s stock worth $13,332,000 after buying an additional 31,274 shares in the last quarter. Babson Capital Management LLC raised its stake in shares of Varian Medical Systems by 39.1% in the first quarter. Babson Capital Management LLC now owns 24,171 shares of the company’s stock valued at $1,934,000 after buying an additional 6,800 shares during the period. Royal Bank of Canada raised its stake in shares of Varian Medical Systems by 3.6% in the first quarter. Royal Bank of Canada now owns 270,579 shares of the company’s stock valued at $21,650,000 after buying an additional 9,281 shares during the period. BNP Paribas Arbitrage SA raised its stake in shares of Varian Medical Systems by 31.8% in the second quarter. BNP Paribas Arbitrage SA now owns 33,581 shares of the company’s stock valued at $2,761,000 after buying an additional 8,109 shares during the period. Finally, Raymond James Trust N.A. raised its stake in shares of Varian Medical Systems by 10.0% in the second quarter. Raymond James Trust N.A. now owns 3,348 shares of the company’s stock valued at $275,000 after buying an additional 304 shares during the period. 99.11% of the stock is currently owned by institutional investors.

Shares of Varian Medical Systems Inc. (NYSE:VAR) traded up 0.16% on Friday, reaching $91.77. The company’s stock had a trading volume of 26,281 shares. The stock has a 50-day moving average of $92.99 and a 200 day moving average of $90.28. The stock has a market capitalization of $8.60 billion, a PE ratio of 21.90 and a beta of 0.67. Varian Medical Systems Inc. has a 1-year low of $73.18 and a 1-year high of $106.70.

Varian Medical Systems (NYSE:VAR) last posted its quarterly earnings data on Wednesday, October 26th. The company reported $1.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.34 by $0.04. The business earned $912 million during the quarter, compared to analysts’ expectations of $880.29 million. Varian Medical Systems had a net margin of 12.51% and a return on equity of 26.57%. The business’s revenue was up 11.5% on a year-over-year basis. During the same period last year, the firm posted $1.04 earnings per share. On average, equities analysts forecast that Varian Medical Systems Inc. will post $4.93 EPS for the current year.

Several equities research analysts have recently commented on the company. Jefferies Group reissued a “buy” rating and set a $98.00 price target on shares of Varian Medical Systems in a research note on Wednesday, September 28th. Robert W. Baird boosted their price target on Varian Medical Systems from $91.00 to $99.00 and gave the stock a “neutral” rating in a research note on Wednesday, September 28th. Zacks Investment Research raised Varian Medical Systems from a “hold” rating to a “buy” rating and set a $109.00 price target on the stock in a research note on Tuesday, September 27th. BTIG Research reissued a “hold” rating on shares of Varian Medical Systems in a research note on Monday, October 31st. Finally, Barrington Research decreased their price target on Varian Medical Systems from $102.00 to $93.00 and set an “outperform” rating on the stock in a research note on Thursday, July 28th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $93.38.

In related news, insider Dow R. Wilson sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $96.08, for a total transaction of $960,800.00. Following the completion of the sale, the insider now directly owns 70,598 shares in the company, valued at $6,783,055.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP John W. Kuo sold 4,073 shares of the firm’s stock in a transaction that occurred on Thursday, September 15th. The stock was sold at an average price of $95.47, for a total transaction of $388,849.31. Following the sale, the senior vice president now owns 28,100 shares of the company’s stock, valued at $2,682,707. The disclosure for this sale can be found here. 0.86% of the stock is currently owned by insiders.

Varian Medical Systems Company Profile

Varian Medical Systems Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection.

Related posts

Leave a Comment